Effects of Paddle-Shaft Position and Inclination of Dissolution Apparatus on the Dissolution Rate of Carbamazepine Tablets and the Equivalence Assessment of Generic Drugs

被引:0
|
作者
Fujimoto, Mari [2 ,3 ]
Mihara, Kiyoshi [1 ,3 ]
Jorgenson, James A. [4 ]
Otsuka, Kuniko [5 ]
Aburada, Masaki [1 ,3 ]
Kawada, Tomie [1 ]
Ishizaki, Junko [2 ]
Miyamoto, Ken-ichi [2 ]
Otsuka, Makoto [1 ]
机构
[1] Musashino Univ, Fac Pharm, Pharmaceut Sci Res Inst, Tokyo 2028585, Japan
[2] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan
[3] Musashino Univ, Fac Pharm, Res Ctr Clin Pharm, Tokyo 2028585, Japan
[4] Univ Utah, Dept Hosp Pharm, Salt Lake City, UT 84132 USA
[5] Yokohama Coll Pharm, Yokohama, Kanagawa 2450066, Japan
来源
DISSOLUTION TECHNOLOGIES | 2010年 / 17卷 / 02期
关键词
VARIABILITY;
D O I
10.14227/DT170210P36
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dissolution testing is useful for controlling the quality of an oral generic equivalent (GE) drug and rejecting a bioinequivalent GE. However, several sources of variability in dissolution tests can affect evaluations of drug quality. Recently, we reported that shifting the paddle shaft off-center significantly changed the dissolution rate of sodium diclofenac tablets, with the result that some GE tablets did not meet the criteria for equivalence. The aim of this study was to confirm the effect of paddle position and to investigate the effect of inclining the dissolution apparatus on the dissolution rates, quality assessment, and equivalence assessment of rapid-release carbamazepine tablets using a brand product (BR) and three GE products. Dissolution tests were carried out on the basis of the Japanese Pharmacopoeia (JP) 15 and Japanese Orange Book paddle methods. The paddle was shifted 5 mm from the center of the vessel, and the dissolution apparatus was inclined backward approximately 4 degrees from the horizontal position. The percentage of drug that dissolved was then calculated. Shifting the paddle significantly increased the dissolution rate for all tablets, whereas inclining the apparatus reduced the dissolution rate for some tablets. All carbamazepine tablets passed the quality evaluation, and all GE products were judged equivalent to the BR product when the paddle was positioned centrally and the apparatus was horizontal. However, the BR product did not meet the criteria of the quality evaluation, and one GE product was judged not equivalent to the BR product in the 5-mm-off-center experiment, suggesting that the position of the paddle affects the quality and equivalence assessment of the rapid-release carbamazepine tablets. In conclusion, offsetting the paddle position from the center could affect the equivalence, as well as the quality assessment, of GEs by enhancing the dissolution rate. Inclining the apparatus reduced the dissolution rate but did not affect the equivalence assessment of GEs.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 4 条
  • [1] Effect of Paddle-Shaft Position on the Dissolution Rate of Sodium Diclofenac Tablets and the Equivalence Assessment of a Generic Product
    Fujimoto, Mari
    Mihara, Kiyoshi
    Jorgenson, James A.
    Otsuka, Kuniko
    Aburada, Masaki
    Kawada, Tomie
    Ishizaki, Junko
    Miyamoto, Ken-ichi
    Otsuka, Makoto
    [J]. DISSOLUTION TECHNOLOGIES, 2009, 16 (04): : 29 - 34
  • [2] Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability
    D'Arcy, DM
    Corrigan, OI
    Healy, AM
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (10) : 1243 - 1250
  • [3] EFFECT OF APPARATUS CONSTRUCTION ON DISSOLUTION RATE DATA OF DRUGS FROM TABLETS
    STOZEK, T
    KROWCZYNSKI, L
    KALETAZUREK, E
    [J]. ACTA POLONIAE PHARMACEUTICA, 1979, 36 (05): : 583 - 589
  • [4] EVALUATION OF THE FLOW-THROUGH CELL DISSOLUTION APPARATUS - EFFECTS OF FLOW-RATE, GLASS-BEADS AND TABLET POSITION ON DRUG-RELEASE FROM DIFFERENT TYPE OF TABLETS
    ZHANG, GH
    VADINO, WA
    YANG, TT
    CHO, WP
    CHAUDRY, IA
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (13) : 2063 - 2078